September 11, 2001
We Remember.
Today we honor the lives lost, the firefighters and police officers who ran toward the towers, the service members who answered after, and the families who carry that morning with them still.
One nation. Never forgotten.
Elevate Chicago
Physician-Led · 100% Virtual · Nationwide
Live Longer.
Perform Better.
Elevate your life.
Elevate Chicago is a physician-led hormone optimization and peptide therapy practice serving patients nationwide — 100% virtual. Comprehensive labs, precise protocols, and a physician who answers.
Medicine for people who refuse to plateau.
Most care is built to keep you out of disease. We build for the other end of the curve — the version of you that trains harder, thinks sharper and recovers faster at fifty than you did at thirty.
About Elevate Chicago
A hormone and peptide practice, run by physicians.
Elevate Chicago is a physician-led hormone optimization and peptide therapy practice serving patients nationwide. We are a telehealth practice — there is no waiting room and no office visit. Patients complete a 65-biomarker baseline panel at a Quest Diagnostics location near them, meet their physician for a video visit, and receive a protocol shipped to their door.
We work with men and women who are already high functioning: executives, endurance and strength athletes, operators, and people in perimenopause or andropause who were told their labs looked “normal” and know better. Prescribed therapies are dispensed through FDA-registered compounding pharmacies and licensed pharmacy partners when available.
Founders
Built by people who live the standard.
Frank Muscarello
Founder · Entrepreneur
Frank built Elevate Chicago on a simple conviction: the people carrying the most — operators, executives, athletes, parents — deserve medicine that works as hard as they do. A serial entrepreneur with decades of experience building and scaling companies, he leads the practice's vision, operations and relentless focus on patient experience.
@frankmuscarello
Ryan Foley
Founder · Professional Athlete
Ryan is a world champion professional athlete and Ironman who knows exactly what optimized human performance requires — because his career depends on it. A former Google executive turned full-time athlete, he brings the discipline of elite competition and the rigor of data-driven decision-making to everything Elevate Chicago builds.
@grfoleyOur Team
The clinicians behind every protocol.
Dr. Eric W. Anderson, MD
Medical Director
Medical Director. An Illinois-licensed physician and surgeon, fellowship trained at the University of Utah, whose practice spans GLP-1 weight management, testosterone therapy, and post-weight-loss body contouring.
Dr. Susan Bray, DNP
Doctor of Nursing Practice
Dr. Bray brings doctoral-level clinical expertise in hormone replacement, women's health and bioidentical therapy. She specializes in helping patients navigate perimenopause, andropause and the hormonal shifts that quietly drag down energy, sleep and performance.
The Approach
No clinic. No waiting room.
Just the physician.
Elevate Chicago is entirely telehealth. Your baseline labs are drawn at a Quest location near you, your protocol ships to your door, and your physician is a message away. Nothing about your care requires you to sit in a lobby.
Physician-designed, not protocol-picked
Every plan is written for one person's biomarkers and one person's goals.
Data before decisions
A 65-biomarker panel first. We treat numbers and symptoms, never one without the other.
Built for output
Success is measured in training, focus, sleep and recovery — not just reference ranges.
Programs
Six ways we move the needle.
Hormone Optimization
The foundation. Testosterone, estradiol, progesterone and thyroid — measured properly, prescribed through a licensed compounding pharmacy, and titrated to how you actually feel.
Learn more →02Prescription · Requires ConsultationPeptide Therapy
Targeted peptide education for recovery, lean mass, sleep architecture and tissue repair — reviewed with a physician, not presented as a menu.
Learn more →03Prescription · Requires ConsultationMetabolic & Weight
GLP-1 and metabolic protocols built to preserve muscle and performance while body composition changes.
Learn more →04Prescription · Requires ConsultationLongevity & Healthspan
Advanced biomarker panels, cardiovascular and cognitive risk mapping, and a protocol designed for the next thirty years.
Learn more →05Prescription · Requires ConsultationSexual Health & Vitality
Discreet, evidence-based treatment for libido, function and energy — addressed at the hormonal root.
Learn more →06Prescription · Requires ConsultationPerformance Recovery
For athletes and operators: injury recovery, sleep, inflammation and training load support between competition blocks.
Learn more →Featured Peptides
A few of the tools in the toolkit.
These are educational examples of compounds discussed across recovery, sleep, body composition and metabolic care. They do not guarantee availability. Physician-supervised treatment and research-use products are separate offerings with different requirements.
BPC-157
Research interest in gut, tendon and soft-tissue repair
TB-500 / Thymosin Beta-4
Research interest in systemic tissue healing and mobility
Sermorelin
Growth-hormone-axis education for recovery and sleep
Ipamorelin + CJC-1295
Research into recovery, sleep and lean-mass signaling
Single Regulator (GLP-1) — semaglutide
Semaglutide, listed as Single Regulator (GLP-1) because compounded formulations cannot be marketed under the drug's commercial name. A GLP-1 medication containing an active ingredient also found in FDA-approved products; compounded formulations are not themselves FDA-approved.
Dual Regulator (GLP-1/GIP) — tirzepatide
Tirzepatide, listed as Dual Regulator (GLP-1/GIP) because compounded formulations cannot be marketed under the drug's commercial name. A GIP/GLP-1 medication containing an active ingredient also found in FDA-approved products; compounded formulations are not themselves FDA-approved.
Explore the complete educational reference, including repair, longevity, cognitive and hormonal compounds.
Explore all peptidesWhen a suitable prescription formulation is not legally available through a compounding pharmacy, certain compounds may be offered separately for lawful laboratory or research use only. They are not FDA-approved medications, are not prescribed as medical care, and are not for human or animal consumption. Availability and eligibility depend on applicable law and current supplier status.
Start Reading
The pages patients read first.
Educational one-pagers on the compounds and hormones we are asked about most — what each one is, what has actually been studied, and what a physician looks at before prescribing anything.
BPC-157
A synthetic pentadecapeptide studied in preclinical models of tendon, ligament and gut-lining repair.
Sermorelin
A growth-hormone-releasing hormone analog that prompts your own pituitary pulse rather than replacing it.
Ipamorelin
A selective growth-hormone secretagogue studied for recovery and sleep with minimal cortisol or prolactin effect.
CJC-1295
A long-acting GHRH analog usually discussed alongside ipamorelin to extend the growth-hormone pulse.
Tesamorelin
An FDA-approved GHRH analog with human trial data on visceral adipose tissue reduction.
MOTS-c
A mitochondrial-derived peptide studied for metabolic flexibility, insulin signaling and exercise capacity.
IGF-1
The downstream growth factor that growth-hormone therapy is actually titrated against, and the marker we track on labs.
NAD+ / NMN
Cellular energy substrates studied for mitochondrial function, DNA repair signaling and age-related NAD+ decline.
Testosterone
What free and total testosterone actually mean, what else has to be measured, and how therapy is dosed and monitored.
Estrogen
Estradiol in both men and women — why it is not a number to crush, and how perimenopausal therapy is designed.
The Clinical Path
Consultation. Bloodwork. Protocol.
Hormone and peptide therapy at Elevate is physician-prescribed and pharmacy-dispensed — it always starts with a consultation and labs. This is separate from our Research Use Only shop, which is not prescribed and not for human use.
Apply & Book
A $100 application fee reserves your intake — and is credited toward your first order.
Baseline Labs
A 65-biomarker panel drawn at a Quest Diagnostics location near you. All labs — baseline and follow-up — are done at Quest, never at home.
Physician Video Visit
A video visit with your physician: every value, every symptom, your training and your goals.
Your Protocol
A physician-designed protocol shipped to your door with dosing, timing and coaching built in.
Ongoing Optimization
Repeat Quest labs and continual titration. The protocol moves as your biology and your season move.
$100 Application Credit
Your $100 application fee is credited toward your first order.
Patients
What changes when the medicine keeps up.
“I had been told my labs were normal for six years. Ninety days in, I am sleeping through the night and training like I did at thirty-two.”
“The difference is the physician actually reads the panel with you. Nothing is prescribed that they cannot explain.”
“I lost thirty-one pounds and kept my strength numbers. That was the whole point, and nobody else was planning for it.”
Individual results vary and are not typical or guaranteed. Testimonials reflect individual experiences under physician-supervised care. These statements have not been evaluated by the FDA and are not medical advice.
Research & Regulatory Watch
Peptides, longevity and the FDA, tracked.
Access to peptide therapeutics is changing quickly. We follow it closely so your protocol stays both current and compliant.
Triple regulator (retatrutide): where it actually stands
Our live tracker on the GLP-1/GIP/glucagon triple regulator — phase 3 TRIUMPH readouts, weight and liver-fat data, both estimands, and the realistic path to availability.
The six peptides at the front of the FDA line — 503A status board
BPC-157 and TB-500 (Thymosin Beta-4) lead the group of six peptides advanced for the 503A bulks list, alongside Thymosin Alpha-1, Epitalon, KPV and LL-37. We track filing status and vote counts so protocols move the day access opens.
What the PCAC peptide vote means for compounding pharmacies
A practical breakdown of how the advisory committee's recommendations change what 503A pharmacies can compound — and the timeline before anything becomes binding.
FDA advisers support easing restrictions on six peptides
An FDA advisory committee voted to open the door for six peptides to be dispensed by compounding pharmacies — a meaningful shift in access for physician-supervised protocols.
What the advisory vote does — and doesn't — actually do
The vote is a recommendation, not a rule. This is the clearest read on what changes now versus what still requires formal FDA action.
An FDA committee voted in favor of peptides — despite agency opposition
Committee members sided with clinical experience over FDA staff objections, citing years of real-world physician use and safety data.
Begin
Your next decade starts with one conversation.
Reach out and we'll schedule your virtual consultation. Serving high performers from Chicago, nationwide.
Begin Your Intake
Complete the booking and intake form — your goals, training background and what you are optimizing for — and a member of the clinical team responds within one business day to confirm your video visit.
Start Your IntakeYour health information
Elevate Chicago operates as a HIPAA-covered entity. Visits, messages, and lab results are handled on encrypted, access-controlled systems, and we maintain Business Associate Agreements with the vendors that touch your protected health information. We do not sell patient data, and we do not use it for advertising.
Where we practice
Elevate Chicago clinicians are licensed in Illinois, Florida, New York, and Texas. We're expanding — join the waitlist and we'll contact you when we can see patients in your state.
How we talk about the evidence
We publish what the research supports and what it doesn't, including where the evidence is thin. Our regulatory tracker is updated as the FDA docket moves.